There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain microproteins that store fat.In findings published in the Proceedings of the National ...

Mounjaro is the brand name for a drug called tirzepatide, which is a glucagon-like peptide-1 (GLP-1) that helps to lower ...

Raisin water, touted as a health elixir by online gurus, faces scrutiny regarding its purported benefits. While whole raisins ...

Jillian Michaels joins 'Fox & Friends' to discuss falling U.S. drinking rates and a new study linking walking to fat burning ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Ozempic and drugs like it have done wonders for weight loss by mimicking the natural hormone GLP-1 ( glucagon-like peptide-1 ...

A recent study compared the benefits of the 12-3-30 workout to running. Experts parse the results to tell us which is the ...

Eli Lilly will raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170% to be in line ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

What hits you first is the exhaustion carved into every face. The sickly pallor. The terrifying weight loss ravaging everyone ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.